Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kirshenbaum

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Circulation|October 1, 1987
Time course of resolution of pulmonary hypertension and right ventricular remodeling after orthotopic cardiac transplantationS J Bhatia, J M Kirshenbaum, R J Shemin, et al.
Journal of the American College of Cardiology|December 1, 1994
Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trialC P Cannon, C H McCabe, D J Diver, et al.
American Heart Journal|January 7, 2003
No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary interventionFrederic S Resnic, Marco Wainstein, Michael K Y Lee, et al.
The American Journal of Cardiology|May 31, 2014
Comparison of the use of downstream tests after exercise treadmill testing by cardiologists versus noncardiologistsMarcio S Bittencourt, Mitalee P Christman, Edward Hulten, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Circulation|October 1, 1987
Time course of resolution of pulmonary hypertension and right ventricular remodeling after orthotopic cardiac transplantationS J Bhatia, J M Kirshenbaum, R J Shemin, et al.
Journal of the American College of Cardiology|December 1, 1994
Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trialC P Cannon, C H McCabe, D J Diver, et al.
American Heart Journal|January 7, 2003
No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary interventionFrederic S Resnic, Marco Wainstein, Michael K Y Lee, et al.
The American Journal of Cardiology|May 31, 2014
Comparison of the use of downstream tests after exercise treadmill testing by cardiologists versus noncardiologistsMarcio S Bittencourt, Mitalee P Christman, Edward Hulten, et al.
Pageof 5